Hormone therapy is suitable for treating breast cancer that relies on female hormones (estrogen and/or progesterone) to grow. Its mechanism of action is to reduce the production of these hormones or to prevent them from touching the cancer cells and having an effect. It is recommended that women with hormone-positive (ER-positive and/or PR-positive) breast cancer receive hormone treatment at some point in their treatment journey. Before choosing the right hormone therapy, all factors should be considered, such as whether the patient has reached menopause or not.
Hormone therapy is usually given for 5 to 10 years. If the patient has any side effects during treatment, the attending doctor should be informed immediately so that they can assess whether the patient’s status is ideal. This will allow the patient to have the best treatment. In general, hormone therapy is given orally, though some drugs are given by injection.
Image under license from shutterstock.com
This article is created and owned by Roche Hong Kong
References:
- Hong Kong Cancer Fund. Breast Cancer Booklet. https://www.cancer-fund.org/wp-content/uploads/2017/04/Breast-Cancer-Pdf-2010E.pdf. Accessed February 2022.
- Hong Kong Breast Cancer Foundation. Hormonal Therapy. Available at: https://www.hkbcf.org/en/breast_cancer/main/89, accessed February 2022.
- Hospital Authority Smart Patient website. Breast Cancer. Available at: https://www21.ha.org.hk/smartpatient/SPW/en-US/Disease-Information/Disease/?guid=bc5c075d-d161-4abc-9b1b-1b1ca15d6947, accessed in February 2022.
- American Cancer Society. Hormone Therapy for Breast Cancer. Available at: https://www.cancer.org/cancer/breast-cancer/treatment/hormone-therapyfor-breast-cancer.html, accessed in February 2022.
- Breastcancer.org. Staying on Track with Hormonal Therapy. Available at: https://www.breastcancer.org/treatment/hormonal/on_track, accessed in February 2022.